News
EKTAY
6.04
-2.27%
-0.14
Elekta upgraded to Buy from Add at AlphaValue/Baader
TipRanks · 09/07 12:15
J.P. Morgan Reaffirms Their Sell Rating on Elekta AB (0O5H)
TipRanks · 09/02 12:17
Barclays Sticks to Their Sell Rating for Elekta AB (0O5H)
TipRanks · 09/02 01:46
Elekta price target lowered to SEK 46.20 from SEK 52 at JPMorgan
TipRanks · 08/28 15:30
Elekta AB earnings call: margins up, growth uneven
TipRanks · 08/28 00:06
Elekta AB Non-GAAP EPS of SEK 0.69, revenue of SEK 3.54B; reaffirms full-year outlook
Seeking Alpha · 08/27 08:50
Elekta price target lowered to SEK 52 from SEK 60 at Deutsche Bank
TipRanks · 06/22 16:00
Elekta downgraded to Hold from Buy at SEB Equities
TipRanks · 05/29 08:50
Elekta Non-GAAP EPS of SEK 0.57, revenue of SEK 4.76B; gives fiscal year 2026/27 outlook
Seeking Alpha · 05/28 07:49
UBS downgrades Elekta AB (0O5H) to a Sell
TipRanks · 05/21 16:48
Elekta AB: Tricky, But With A Latent Upside
Seeking Alpha · 05/19 14:58
Elekta downgraded to Sell from Hold at Danske Bank
TipRanks · 03/25 09:40
Elekta AB (0O5H) Gets a Hold from Kepler Capital
TipRanks · 03/14 11:35
Elekta price target raised to SEK 60 from SEK 49 at Deutsche Bank
TipRanks · 03/13 16:47
Elekta AB (0O5H) Gets a Hold from Kepler Capital
TipRanks · 03/07 17:56
Elekta AB Earnings Call: Margin Gains Amid Headwinds
TipRanks · 03/06 00:03
Groundhog Day Once Again, As Accuray Misses And Lowers
Seeking Alpha · 02/06 06:38
Kepler Capital Reaffirms Their Hold Rating on Elekta AB (0O5H)
TipRanks · 02/04 02:49
Elekta Wins FDA Nod for Evo CT-Linac, Boosting U.S. Radiation Oncology
NASDAQ · 01/19 17:40
Elekta price target lowered to SEK 52 from SEK 61 at JPMorgan
TipRanks · 12/08/2025 17:21
More
Webull provides a variety of real-time EKTAY stock news. You can receive the latest news about Elekta Ab through multiple platforms. This information may help you make smarter investment decisions.
About EKTAY
Elekta AB (publ) is a Sweden-based medical technology company which aims to improve, prolong and save lives through clinical solutions for treating cancer and brain disorders. The Company offers and develops systems for radiation therapy and radio-surgery, as well as software systems that enhance workflow efficiency throughout the entire spectrum of cancer care. Elekta AB (publ) develops clinical treatment solutions for radiation therapy and radiosurgery, as well as work flow-enhancing software systems, across the spectrum of cancer care. The Company provides clinical solutions for image guided radiation therapy and stereotactic radiosurgery, giving oncologists and neurosurgeons an unmatched capability to treat tumors and functional targets with ultra-high precision while sparing healthy tissue.